The healthtech startup Farmaku announced the acquisition of DokterSehat, which was held last November for an undisclosed amount. Post-acquisition, both platforms can still be accessed as per usual. DokterSehat’s CEO Indra Adam Darmawan is appointed as Farmaku’s CMO.
Farmaku is a platform that provides drug purchase services, while DokterSehat focuses on health information portals. Both have been operating for at least 4 years.
“Farmaku has previously collaborated with DokterSehat, therefore, this strategic merger is expected to provide more comprehensive health services to the Indonesian people,” Farmaku’s CEO Iswandi Simardjo said.
Indra added, “This acquisition is expected to complement the wider ecosystem in terms of transactional and providing health information in Indonesia.”
The healthtech sector is one of the sectors that experience massive acceleration due to pandemic. In Indonesia, there are two startups that have reached the centaur level (valuation above $100 million), Halodoc and Alodokter.
Apart from health information portals and drug delivery, startups in this segment have been moving towards developing smart clinics and biotech startups.
–
Original article is in Indonesian, translated by Kristin Siagian
